Vav1 HAPLOINSUFFICIENCY IN A COMMON VARIABLE IMMUNODEFICIENCY PATIENT WITH DEFECTIVE T-CELL FUNCTION

被引:19
作者
Capitani, N. [2 ]
Ariani, F. [3 ]
Amedei, A. [1 ]
Pezzicoli, A. [2 ]
Matucci, A. [4 ]
Vultaggio, A. [4 ]
Troilo, A. [1 ]
Renieri, A. [3 ]
Baldari, C. T. [2 ]
D'Elios, M. M. [1 ]
机构
[1] Univ Florence, Dept Internal Med, I-50134 Florence, Italy
[2] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy
[3] Univ Siena, Med Genet Unit, Dept Mol Biol, I-53100 Siena, Italy
[4] Policlin AOU Careggi, SOD Immunoallergol, Florence, Italy
关键词
CVID; Vav; gene dosage; gene expression; TCR signaling; ANTIGEN RECEPTOR; EXCHANGE FACTOR; B-CELLS; ACTIVATION; EXPRESSION; ORGANIZATION; REGULATOR; PROTEINS; SUBSET; FAMILY;
D O I
10.1177/039463201202500332
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Common variable immunodeficiency (CVID) is a primary immune disorder characterized by impaired antibody production, which is in many instances secondary to defective T cell function (T-CVID). We previously identified a subset of T-CVID patients characterized by defective expression of Vav1, a guanine nucleotide exchanger which couples the T-cell antigen receptor to reorganization of the actin cytoskeleton. Here we have addressed the possibility that an intrinsic defect in the Vav1 gene might underlie the reduction in Vav protein observed in T cells from these patients. We report the identification in one T-CVID patient of a heterozygous deletion in Vav1. The gene deletion, spanning exons 2-27, accounts for the reduction in Vav1 mRNA and protein in T cells from this patient. The disease-related pedigree of this patient suggests a de novo origin of the Vav1 deletion. The findings highlights Vav1 as an autosomal dominant disease gene associated with CVID with defective T-cell function.
引用
收藏
页码:811 / 817
页数:7
相关论文
共 26 条
[1]   Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency [J].
Aspalter, Rosa M. ;
Eibl, Martha M. ;
Wolf, Hermann M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (05) :1193-1200
[2]  
Bachmann MF, 1999, J IMMUNOL, V163, P137
[3]  
Boncristiano M, 2000, EUR J IMMUNOL, V30, P2632, DOI 10.1002/1521-4141(200009)30:9<2632::AID-IMMU2632>3.0.CO
[4]  
2-C
[5]   Primary immunodeficiency diseases due to defects in lymphocytes. [J].
Buckley, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (18) :1313-1324
[6]   Regulatory and signaling properties of the Vav family [J].
Bustelo, XR .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1461-1477
[7]   Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defects [J].
Capitani, Nagaja ;
Amedei, Amedeo ;
Paccani, Silvia Rossi ;
Matucci, Andrea ;
Vultaggio, Alessandra ;
Del Prete, Gianfranco ;
Baldari, Cosima T. ;
D'Elios, Mario M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (03) :671-675
[8]   Cbl Enforces Vav1 Dependence and a Restricted Pathway of T Cell Development [J].
Chiang, Jeffrey ;
Hodes, Richard J. .
PLOS ONE, 2011, 6 (04)
[9]   Genomic organization and regulation of the vav proto-oncogene [J].
Denkinger, DJ ;
Borges, CR ;
Butler, CL ;
Cushman, AM ;
Kawahara, RS .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1491 (1-3) :253-262
[10]   TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts [J].
Drevot, P ;
Langlet, C ;
Guo, XJ ;
Bernard, AM ;
Colard, O ;
Chauvin, JP ;
Lasserre, R ;
He, HT .
EMBO JOURNAL, 2002, 21 (08) :1899-1908